DSGN
DSGN
US25056L1035
Design Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
729.08M EUR
905.53M EUR
664.38M EUR
566.53M EUR
Enterprise Value
514.33M EUR
895.29M EUR
654.34M EUR
551.21M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.2x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.61x
4.49x
3.05x
2.67x
EV/Revenue
--
--
--
--
EV/EBITDA
-6.57x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.44%
-6.09%
-8.15%
-6.65%
ende